Form EFFECT GT Biopharma, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GT Biopharma integrates AI tools to accelerate drug discovery
- XRP News: ETF Inflows Near $1.4B as MemeToro Gains Attention Following Rapid Ecosystem Growth
- Best Cryptos To Buy In Bear Market: 5 Picks as BTC Falls Below $62K and Market Confidence Weakens
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
